BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1579323)

  • 1. Intrauterine release of levonorgestrel--a new way of adding progestogen in hormone replacement therapy.
    Andersson K; Mattsson LA; Rybo G; Stadberg E
    Obstet Gynecol; 1992 Jun; 79(6):963-7. PubMed ID: 1579323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrauterine or oral administration of levonorgestrel in combination with estradiol to perimenopausal women--effects on lipid metabolism during 12 months of treatment.
    Andersson K; Stadberg E; Mattsson LA; Rybo G; Samsioe G
    Int J Fertil Menopausal Stud; 1996; 41(5):476-83. PubMed ID: 8934257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints: clinical and endometrial responses.
    Raudaskoski TH; Lahti EI; Kauppila AJ; Apaja-Sarkkinen MA; Laatikainen TJ
    Am J Obstet Gynecol; 1995 Jan; 172(1 Pt 1):114-9. PubMed ID: 7847516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endometrial morphology during hormone replacement therapy with estradiol gel combined to levonorgestrel-releasing intrauterine device or natural progesterone.
    Suvanto-Luukkonen E; Malinen H; Sundström H; Penttinen J; Kauppila A
    Acta Obstet Gynecol Scand; 1998 Aug; 77(7):758-63. PubMed ID: 9740525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative study of the effects of an estradiol-releasing vaginal ring combined with an oral gestagen versus transdermal estrogen combined with a levonorgestrel-releasing IUD: clinical findings and endometrial response.
    Kalogirou D; Antoniou G; Karakitsos P; Kalogirou O; Antoniou D; Giannikos L
    Int J Fertil Menopausal Stud; 1996; 41(6):522-7. PubMed ID: 9010746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transdermal estrogen with a levonorgestrel-releasing intrauterine device for climacteric complaints versus estradiol-releasing vaginal ring with a vaginal progesterone suppository: clinical and endometrial responses.
    Antoniou G; Kalogirou D; Karakitsos P; Antoniou D; Kalogirou O; Giannikos L
    Maturitas; 1997 Mar; 26(2):103-11. PubMed ID: 9089559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrauterine 10 microg and 20 microg levonorgestrel systems in postmenopausal women receiving oral oestrogen replacement therapy: clinical, endometrial and metabolic response.
    Raudaskoski T; Tapanainen J; Tomás E; Luotola H; Pekonen F; Ronni-Sivula H; Timonen H; Riphagen F; Laatikainen T
    BJOG; 2002 Feb; 109(2):136-44. PubMed ID: 11888095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levonorgestrel intrauterine system (LNG-IUS) with conjugated oral equine estrogen: a successful regimen for HRT in perimenopausal women.
    Hampton NR; Rees MC; Lowe DG; Rauramo I; Barlow D; Guillebaud J
    Hum Reprod; 2005 Sep; 20(9):2653-60. PubMed ID: 15905289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparing the effects of intrauterine progestin system and oral progestin on health-related quality of life and Kupperman index in hormone replacement therapy.
    Pirimoglu ZM; Ozyapi AG; Kars B; Buyukbayrak EE; Solak Y; Karsidag AY; Unal O; Turan MC
    J Obstet Gynaecol Res; 2011 Oct; 37(10):1376-81. PubMed ID: 21599801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of a transdermal continuous combined and an interrupted progestogen HRT.
    Cameron ST; Glasier AF; Gebbie A; Dewart H; Baird DT
    Maturitas; 2006 Jan; 53(1):19-26. PubMed ID: 16325020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levonorgestrel-releasing intrauterine device versus hysteroscopic endometrial resection in the treatment of dysfunctional uterine bleeding.
    Crosignani PG; Vercellini P; Mosconi P; Oldani S; Cortesi I; De Giorgi O
    Obstet Gynecol; 1997 Aug; 90(2):257-63. PubMed ID: 9241305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of dysfunctional uterine bleeding: patient preferences for endometrial ablation, a levonorgestrel-releasing intrauterine device, or hysterectomy.
    Bourdrez P; Bongers MY; Mol BW
    Fertil Steril; 2004 Jul; 82(1):160-6, quiz 265. PubMed ID: 15237006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endometrial safety with a low-dose intrauterine levonorgestrel-releasing system after 3 years of estrogen substitution therapy.
    Wildemeersch D; Schacht E; Wildemeersch P; Calleweart K; Pylyser K; De Wever N
    Maturitas; 2004 May; 48(1):65-70. PubMed ID: 15223110
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrauterine levonorgestrel delivered by a frameless system, combined with systemic estrogen: acceptability and endometrial safety after 3 years of use in peri- and postmenopausal women.
    Wildemeersch D; Janssens D; Schacht E; Pylyser K; de Wever N
    Gynecol Endocrinol; 2005 Jun; 20(6):336-42. PubMed ID: 16019384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years)].
    Imperato F; Perniola G; Mossa B; Marziani R; Perniola F; Stragapede B; Napolitano C
    Minerva Ginecol; 2002 Jun; 54(3):271-8. PubMed ID: 12063443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intrauterine administration of levonorgestrel 5 and 10 microg/24 hours in perimenopausal hormone replacement therapy. A randomized clinical study during one year.
    Wollter-Svensson LO; Stadberg E; Andersson K; Mattsson LA; Odlind V; Persson I
    Acta Obstet Gynecol Scand; 1997 May; 76(5):449-54. PubMed ID: 9197448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Digitized assessment of mammographic breast density in patients who received low-dose intrauterine levonorgestrel in continuous combination with oral estradiol valerate: a pilot study.
    Lundström E; Söderqvist G; Svane G; Azavedo E; Olovsson M; Skoog L; von Schoultz E; von Schoultz B
    Fertil Steril; 2006 Apr; 85(4):989-95. PubMed ID: 16580385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of a levonorgestrel-releasing intrauterine device for the symptomatic treatment of uterine myomas.
    Rosa e Silva JC; de Sá Rosa e Silva AC; Cândido dos Reis FJ; Manetta LA; Ferriani RA; Nogueira AA
    J Reprod Med; 2005 Aug; 50(8):613-7. PubMed ID: 16220768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The acceptability of a small intrauterine progestogen-releasing system for continuous combined hormone therapy in early postmenopausal women.
    Sturdee DW; Rantala ML; Colau JC; Zahradnik HP; Riphagen FE;
    Climacteric; 2004 Dec; 7(4):404-11. PubMed ID: 15799612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transdermal sequential and continuous hormone replacement regimens with estradiol and norethisterone acetate in postmenopausal women: effects on the endometrium.
    Johannisson E; Holinka CF; Arrenbrecht S
    Int J Fertil Womens Med; 1997; 42 Suppl 2():388-98. PubMed ID: 9397386
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.